Pure Global AI
NCT06414369Not yet recruiting

Effects of Diatermy in Patients With Fibromyalgia.

Camilo Jose Cela UniversityClinicalTrials.govother
Study focus
Disease/Condition
Fibromyalgia
Drug/Device/Intervention
Diathermy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Camilo Jose Cela University
Timeline & enrollment
Phase
N/A
Start date
May 20, 2024
End date
Jul 01, 2024
Enrollment
30 participants
Primary outcome

Pain (VAS),Pain (algometry)

Summary

Diathermy is a non-invasive pain therapy based on the local application of high-frequency
 electromagnetic waves. This procedure produces deep heat promotes tissue repair and
 influences pain sensitivity. The main characteristic of fibromyalgia (FM) is generalized
 musculoskeletal pain. This may be accompanied by muscle and joint stiffness, sleep and mood
 disorders, anxiety and depression, cognitive dysfunction, and chronic fatigue. Endemic in
 developed countries, with a higher prevalence among women than men, and the etiology is still
 unknown. Diagnosis is made on chronic generalized pain and through the presence of tender
 points. The objective of this study will be to analyze the efficacy of diathermy on pain in
 patients with fibromyalgia

ICD-10 classifications
FibromyalgiaMyalgiaFibrothoraxCervicalgiaEpidemic myalgia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414369
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06414369 through Pure Global AI's free database. This phase not specified trial is sponsored by Camilo Jose Cela University and is currently Not yet recruiting. The study focuses on Fibromyalgia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.